BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ansari S, Yamaoka Y. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity. Toxins (Basel). 2019;11. [PMID: 31752394 DOI: 10.3390/toxins11110677] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 2022;204:692. [DOI: 10.1007/s00203-022-03314-w] [Reference Citation Analysis]
2 Ramai D, Salati M, Pomati G, Amoroso C, Facciorusso A, Botticelli A, Ghidini M. Antibiotics, the microbiome and gastrointestinal cancers: A causal interference? Current Opinion in Pharmacology 2022;67:102315. [DOI: 10.1016/j.coph.2022.102315] [Reference Citation Analysis]
3 Santiago MB, Leandro LF, Rosa RB, Silva MV, Teixeira SC, Servato JPS, Ambrósio SR, Veneziani RCS, Aldana-mejía JA, Bastos JK, Martins CHG. Brazilian Red Propolis Presents Promising Anti-H. pylori Activity in In Vitro and In Vivo Assays with the Ability to Modulate the Immune Response. Molecules 2022;27:7310. [DOI: 10.3390/molecules27217310] [Reference Citation Analysis]
4 Zhang ML, Fan YX, Meng R, Cai WK, Yin SJ, Zhou T, Huang YH, Wang P, Jiang FF, Yang M, He GH. Proton Pump Inhibitors and Cancer Risk: An Umbrella Review and Meta-analysis of Observational Studies. Am J Clin Oncol 2022. [PMID: 36255347 DOI: 10.1097/COC.0000000000000949] [Reference Citation Analysis]
5 Zhou Y, Li T, Ali L. Effects of Quadruple Therapy Combined with Probiotics on Helicobacter Pylori-Related Peptic Ulcer. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/1221190] [Reference Citation Analysis]
6 Wang Z, Shan Y, Wang R, Zhou H, Hu R, Li Y, Zhu J, Yang Y, Liu M. Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from Helicobacter pylori. IJMS 2022;23:11299. [DOI: 10.3390/ijms231911299] [Reference Citation Analysis]
7 Zhang Y, Li X, Shan B, Zhang H, Zhao L. Perspectives from recent advances of Helicobacter pylori vaccines research. Helicobacter 2022;:e12926. [PMID: 36134470 DOI: 10.1111/hel.12926] [Reference Citation Analysis]
8 Zeng J, Xie C, Zhang L, Liu X, Chan MTV, Wu WKK, Chen H. Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies. Int J Mol Sci 2022;23:10941. [PMID: 36142852 DOI: 10.3390/ijms231810941] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Agnarelli A, Vella V, Samuels M, Papanastasopoulos P, Giamas G. Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers 2022;14:4378. [DOI: 10.3390/cancers14184378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Salinas Ibáñez ÁG, Origone AL, Liggieri CS, Barberis SE, Vega AE. Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori. Front Microbiol 2022;13:961958. [DOI: 10.3389/fmicb.2022.961958] [Reference Citation Analysis]
11 Li X, Sun X, Kan C, Chen B, Qu N, Hou N, Liu Y, Han F. COL1A1: A novel oncogenic gene and therapeutic target in malignancies. Pathol Res Pract 2022;236:154013. [PMID: 35816922 DOI: 10.1016/j.prp.2022.154013] [Reference Citation Analysis]
12 Wang L, Yi J, Yin X, Hou J, Chen J, Xie B, Chen G, Wang Q, Wang L, Wang X, Sun J, Huo L, Che T, Wei H. Vacuolating Cytotoxin A Triggers Mitophagy in Helicobacter pylori-Infected Human Gastric Epithelium Cells. Front Oncol 2022;12:881829. [DOI: 10.3389/fonc.2022.881829] [Reference Citation Analysis]
13 Zahmatkesh ME, Jahanbakhsh M, Hoseini N, Shegefti S, Peymani A, Dabin H, Samimi R, Bolori S. Effects of Exosomes Derived From Helicobacter pylori Outer Membrane Vesicle-Infected Hepatocytes on Hepatic Stellate Cell Activation and Liver Fibrosis Induction. Front Cell Infect Microbiol 2022;12:857570. [DOI: 10.3389/fcimb.2022.857570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Miri AH, Kamankesh M, Llopis-lorente A, Liu C, Wacker MG, Haririan I, Asadzadeh Aghdaei H, Hamblin MR, Yadegar A, Rad-malekshahi M, Zali MR. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Front Pharmacol 2022;13:917184. [DOI: 10.3389/fphar.2022.917184] [Reference Citation Analysis]
15 Grosso R, de-Paz M. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations. Pharmaceutics 2022;14:1340. [DOI: 10.3390/pharmaceutics14071340] [Reference Citation Analysis]
16 Sharafutdinov I, Ekici A, Vieth M, Backert S, Linz B. Early and late genome-wide gastric epithelial transcriptome response during infection with the human carcinogen Helicobacter pylori. Cell Insight 2022;1:100032. [DOI: 10.1016/j.cellin.2022.100032] [Reference Citation Analysis]
17 Vital JS, Tanoeiro L, Lopes-oliveira R, Vale FF. Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data. Biomolecules 2022;12:691. [DOI: 10.3390/biom12050691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Magierowska K, Magierowski M. CO in Gastrointestinal Physiology and Protection. Carbon Monoxide in Drug Discovery 2022. [DOI: 10.1002/9781119783435.ch27] [Reference Citation Analysis]
19 Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clin Microbiol Rev 2022;:e0025821. [PMID: 35404105 DOI: 10.1128/cmr.00258-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ru Z, Yu M, Zhu Y, Chen Z, Zhang F, Zhang Z, Ding J. Immmunoinformatics-based design of a multi-epitope vaccine with CTLA-4 extracellular domain to combat Helicobacter pylori. FASEB J 2022;36:e22252. [PMID: 35294065 DOI: 10.1096/fj.202101538RR] [Reference Citation Analysis]
21 O’keefe RN, Carli AL, Baloyan D, Afshar-sterle S, Eissmann MF, Poh AR, Seillet C, Locksley RM, Ernst M, Buchert M. Inhibition of the tuft cell/ILC2 axis reduces gastric tumor development in mice.. [DOI: 10.1101/2022.02.16.480779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Yang H, Yang WJ, Hu B. Gastric epithelial histology and precancerous conditions. World J Gastrointest Oncol 2022; 14(2): 396-412 [DOI: 10.4251/wjgo.v14.i2.396] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Qiang L, Hu J, Tian M, Li Y, Ren C, Deng Y, Jiang Y. Extracellular vesicles from helicobacter pylori-infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis. Helicobacter 2022;:e12877. [PMID: 35099837 DOI: 10.1111/hel.12877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Tilahun M, Gedefie A, Belayhun C, Sahle Z, Abera A. Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis. Infect Drug Resist 2022;15:21-34. [PMID: 35023934 DOI: 10.2147/IDR.S346705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Salinas Ibáñez ÁG, Vallés D, Adaro M, Barberis S, Vega AE. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori. Front Nutr 2021;8:699955. [PMID: 34977105 DOI: 10.3389/fnut.2021.699955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mladenova I. Gastric Cancer and Helicobacter pylori. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_31] [Reference Citation Analysis]
27 Lai Y, Wei W, Du Y, Gao J, Li Z. Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microbes 2022;14:2120747. [PMID: 36070564 DOI: 10.1080/19490976.2022.2120747] [Reference Citation Analysis]
28 Moravvej H, Shahidi-dadras M, Memariani H, Memariani M, Robati RM, Gheisari M. Can Helicobacter pylori serve as a trigger for oral lichen planus? Reviews in Medical Microbiology 2022;33:e57-e62. [DOI: 10.1097/mrm.0000000000000269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yücel O. GER and Helicobacter pylori. Gastroesophageal Reflux in Children 2022. [DOI: 10.1007/978-3-030-99067-1_14] [Reference Citation Analysis]
30 Majumdar K, Ganguly R, Das P. Benign Diseases of the Stomach. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_8] [Reference Citation Analysis]
31 Silvan JM, Martinez-rodriguez AJ. Modulation of inflammation and oxidative stress in Helicobacter pylori infection by bioactive compounds from food components. Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress 2022. [DOI: 10.1016/b978-0-12-823482-2.00029-7] [Reference Citation Analysis]
32 Hussein RA, Al-Ouqaili MTS, Majeed YH. Detection of clarithromycin resistance and 23SrRNA point mutations in clinical isolates of Helicobacter pylori isolates: Phenotypic and molecular methods. Saudi J Biol Sci 2022;29:513-20. [PMID: 35002447 DOI: 10.1016/j.sjbs.2021.09.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ivashkin VT, Maev IV, Lapina TL, Fedorov ED, Sheptulin AA, Trukhmanov AS, Kononov AV, Abdulkhakov RA, Alexeeva OP, Alekseenko SA, Andreev DN, Baranskaya EK, Dekhnich NN, Klyaritskaya IL, Kozlov RS, Kogan EA, Korolev MP, Korochanskaya NV, Kurilovich SA, Livsan MA, Osipenko MF, Pavlov PV, Pirogov SS, Sarsenbaeva AS, Simanenkov VI, Tertychny AS, Tkachev AV, Uspensky YP, Khlynov IB, Tsukanov VV. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2021;31:70-99. [DOI: 10.22416/1382-4376-2021-31-4-70-99] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Matveeva LV, Kapkaeva RH, Chudaikin AN, Soldatova AA, Mosina LM, Kostina YA, Solodovnikova GA. Changes in vascular endothelial growth factor level in <i>Helicobacter pylori</i>-associated gastroduodenal diseases. Russian Journal of Infection and Immunity 2021;12:165-171. [DOI: 10.15789//2220-7619-civ-1654] [Reference Citation Analysis]
35 Shome S, Talukdar AD, Upadhyaya H. Antibacterial activity of curcumin and its essential nanoformulations against some clinically important bacterial pathogens: A comprehensive review. Biotechnol Appl Biochem 2021. [PMID: 34826356 DOI: 10.1002/bab.2289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Teresa Mascellino M, De Angelis M, Al Ismail D, Oliva A. Virulence Markers, Genotypic versus Phenotypic Resistance and New Treatment Strategies in Helicobacter pylori Infection. Helicobacter pylori - From First Isolation to 2021 2021. [DOI: 10.5772/intechopen.97026] [Reference Citation Analysis]
37 Patricia Rendón-huerta E, Abraham García-garcía C, Felipe Montaño Estrada L. Effect of Helicobacter pylori on Tight Junctions in Gastric Epithelia. Helicobacter pylori - From First Isolation to 2021 2021. [DOI: 10.5772/intechopen.96607] [Reference Citation Analysis]
38 Sánchez-zauco N, Pérez-figueroa E, Maldonado-bernal C. Helicobacter pylori; a Way to Gastric Cancer? Helicobacter pylori - From First Isolation to 2021 2021. [DOI: 10.5772/intechopen.97343] [Reference Citation Analysis]
39 Senchukova MA, Tomchuk O, Shurygina EI. Helicobacter pylori in gastric cancer: Features of infection and their correlations with long-term results of treatment. World J Gastroenterol 2021;27:6290-305. [PMID: 34712033 DOI: 10.3748/wjg.v27.i37.6290] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
40 Varon C, Azzi-Martin L, Khalid S, Seeneevassen L, Ménard A, Spuul P. Helicobacters and cancer, not only gastric cancer? Semin Cancer Biol 2021:S1044-579X(21)00219-4. [PMID: 34425210 DOI: 10.1016/j.semcancer.2021.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
41 Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
42 Obaid JMAS, Ayoon ANN, Almurisy ONM, Alshuaibi SMS, Alkhawlani NN. Evaluation of antibody immunochromatography testing for diagnosis of current Helicobacter pylori infection. Pract Lab Med 2021;26:e00245. [PMID: 34386566 DOI: 10.1016/j.plabm.2021.e00245] [Reference Citation Analysis]
43 Jalalpour S, Mirzaee V, Taheri M, Sheikh Fathollahi M, Khorramdelazad H, Jafarzadeh A. Ginger Extract Modulates the Production of Chemokines CCL17, CCL20, CCL22, and CXCL10 and the Gene Expression of Their Receptors in Peripheral Blood Mononuclear Cells from Peptic Ulcer Patients Infected with Helicobacter pylori. Jundishapur J Nat Pharm Prod 2021;16. [DOI: 10.5812/jjnpp.100824] [Reference Citation Analysis]
44 de Brito BB, Lemos FFB, Carneiro CDM, Viana AS, Barreto NMPV, Assis GAS, Braga BDC, Santos MLC, Silva FAFD, Marques HS, Silva NOE, de Melo FF. Immune response to Helicobacter pylori infection and gastric cancer development. World J Meta-Anal 2021; 9(3): 257-276 [DOI: 10.13105/wjma.v9.i3.257] [Reference Citation Analysis]
45 Doulberis M, Pierre NT, Manzini G, Papaefthymiou A, Kountouras J, Klukowska-Rötzler J, Polyzos SA, Srivastava S, Exadaktylos AK, Knuchel J, Kuntzen T, Srivastava DS. Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients. Microorganisms 2021;9:1361. [PMID: 34201748 DOI: 10.3390/microorganisms9071361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
46 Gastli N, Allain M, Lamarque D, Abitbol V, Billoët A, Collobert G, Coriat R, Terris B, Kalach N, Raymond J. Diagnosis of Helicobacter pylori Infection in a Routine Testing Workflow: Effect of Bacterial Load and Virulence Factors. J Clin Med 2021;10:2755. [PMID: 34201588 DOI: 10.3390/jcm10132755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
47 Xue Z, Yang H, Su D, Song X, Deng X, Yu C, Sun C, He L, You Y, Gong Y, Fan D, Sun L, Han X, Fan R, Zhang M, Yan X, Qian J, Zhang J. Geographic distribution of the cagA, vacA, iceA, oipA and dupA genes of Helicobacter pylori strains isolated in China. Gut Pathog 2021;13:39. [PMID: 34130751 DOI: 10.1186/s13099-021-00434-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Silvan JM, Gutierrez-Docio A, Guerrero-Hurtado E, Domingo-Serrano L, Blanco-Suarez A, Prodanov M, Alarcon-Cavero T, Martinez-Rodriguez AJ. Pre-Treatment with Grape Seed Extract Reduces Inflammatory Response and Oxidative Stress Induced by Helicobacter pylori Infection in Human Gastric Epithelial Cells. Antioxidants (Basel) 2021;10:943. [PMID: 34208004 DOI: 10.3390/antiox10060943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Syam AF, Waskito LA, Rezkitha YAA, Simamora RM, Yusuf F, Danchi KE, Bakry AF, Arnelis, Mulya E, Siregar GA, Sugihartono T, Maulahela H, Doohan D, Miftahussurur M, Yamaoka Y. Helicobacter pylori in the Indonesian Malay's descendants might be imported from other ethnicities. Gut Pathog 2021;13:36. [PMID: 34088343 DOI: 10.1186/s13099-021-00432-6] [Reference Citation Analysis]
50 Hsin LJ, Chuang HH, Lin MY, Fang TJ, Li HY, Liao CT, Kang CJ, Chen TC, Huang CG, Yen TC, Lee LA. Laryngeal Helicobacter pylori Infection and Laryngeal Cancer-Case Series and a Systematic Review. Microorganisms 2021;9:1129. [PMID: 34071118 DOI: 10.3390/microorganisms9061129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 González MF, Díaz P, Sandoval-Bórquez A, Herrera D, Quest AFG. Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development. Int J Mol Sci 2021;22:4823. [PMID: 34062919 DOI: 10.3390/ijms22094823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
52 Shen X, Zhang W, Peng C, Yan J, Chen P, Jiang C, Yuan Y, Chen D, Zhu W, Yao M. In vitro anti-bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection. Chin Med 2021;16:33. [PMID: 33865425 DOI: 10.1186/s13020-021-00442-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
53 Zoaiter M, Nasser R, Hage-Sleiman R, Abdel-Sater F, Badran B, Zeaiter Z. Helicobacter pylori outer membrane vesicles induce expression and secretion of oncostatin M in AGS gastric cancer cells. Braz J Microbiol 2021;52:1057-66. [PMID: 33851342 DOI: 10.1007/s42770-021-00490-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Xue Z, You Y, He L, Gong Y, Sun L, Han X, Fan R, Zhai K, Yang Y, Zhang M, Yan X, Zhang J. Diversity of 3' variable region of cagA gene in Helicobacter pylori strains isolated from Chinese population. Gut Pathog 2021;13:23. [PMID: 33849660 DOI: 10.1186/s13099-021-00419-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 González‐sánchez P, Denicola GM. The microbiome(s) and cancer: know thy neighbor(s). J Pathol 2021;254:332-43. [DOI: 10.1002/path.5661] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
56 Capparelli R, Iannelli D. Genetics of Host Protection against Helicobacter pylori Infections. Int J Mol Sci 2021;22:3192. [PMID: 33801073 DOI: 10.3390/ijms22063192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
57 de Souza MPC, de Camargo BAF, Spósito L, Fortunato GC, Carvalho GC, Marena GD, Meneguin AB, Bauab TM, Chorilli M. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections. Crit Rev Microbiol 2021;47:435-60. [PMID: 33725462 DOI: 10.1080/1040841X.2021.1895721] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
58 Yang J, Zhou X, Liu X, Ling Z, Ji F. Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment. Front Microbiol 2021;12:641322. [PMID: 33790881 DOI: 10.3389/fmicb.2021.641322] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
59 Ghazvini K, Yamaoka Y, Karbalaei M, Keikha M. Extragastric infection of Helicobacter pylori and alopecia areata: a systematic review and meta-analysis. Reviews in Medical Microbiology 2022;33:e114-8. [DOI: 10.1097/mrm.0000000000000276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Hedayati MA, Salavati S. Transcriptional Profile of Helicobacter pylori Virulence Genes in Patients with Gastritis and Gastric Cancer. Can J Infect Dis Med Microbiol 2021;2021:1309519. [PMID: 33628350 DOI: 10.1155/2021/1309519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Piscione M, Mazzone M, Di Marcantonio MC, Muraro R, Mincione G. Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship. Front Microbiol 2021;12:630852. [PMID: 33613500 DOI: 10.3389/fmicb.2021.630852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
62 Svistunov A, Osadchuk M, Mironova E, Ogibenina E. Helicobacter pylori infection as a risk factor for gastrointestinal cancer. Profil med 2021;24:105. [DOI: 10.17116/profmed202124111105] [Reference Citation Analysis]
63 Siwińska M, Mucha M, Pyrzanowska A, Szlaur M. PHYTOTHERAPY IN THE PREVENTION AND SUPPORT OF TREATMENT OF HELICOBACTER PYLORI INFECTIONS. Postępy Mikrobiologii - Advancements of Microbiology 2021;60:161-172. [DOI: 10.21307/pm-2019.60.2.13] [Reference Citation Analysis]
64 Krzyżek P, Grande R, Migdał P, Paluch E, Gościniak G. Biofilm Formation as a Complex Result of Virulence and Adaptive Responses of Helicobacter pylori. Pathogens 2020;9:E1062. [PMID: 33353223 DOI: 10.3390/pathogens9121062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
65 Zarzecka U, Matkowska D, Backert S, Skorko-Glonek J. Importance of two PDZ domains for the proteolytic and chaperone activities of Helicobacter pylori serine protease HtrA. Cell Microbiol 2021;23:e13299. [PMID: 33277762 DOI: 10.1111/cmi.13299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Krzyżek P, Gościniak G, Fijałkowski K, Migdał P, Dziadas M, Owczarek A, Czajkowska J, Aniołek O, Junka A. Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate or Sertraline, to Fight against Helicobacter pylori Lawn Biofilm. Int J Mol Sci 2020;21:E9507. [PMID: 33327555 DOI: 10.3390/ijms21249507] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
67 Gupta S, Jain U, Murti BT, Putri AD, Tiwari A, Chauhan N. Nanohybrid-based immunosensor prepared for Helicobacter pylori BabA antigen detection through immobilized antibody assembly with @ Pdnano/rGO/PEDOT sensing platform. Sci Rep 2020;10:21217. [PMID: 33277599 DOI: 10.1038/s41598-020-78068-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
68 Cuomo P, Papaianni M, Sansone C, Iannelli A, Iannelli D, Medaglia C, Paris D, Motta A, Capparelli R. An In Vitro Model to Investigate the Role of Helicobacter pylori in Type 2 Diabetes, Obesity, Alzheimer's Disease and Cardiometabolic Disease. Int J Mol Sci 2020;21:E8369. [PMID: 33171588 DOI: 10.3390/ijms21218369] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
69 Salih BA, Karakus C, Ulupinar Z, Akbas F, Uslu M, Yazici D, Bolek BK, Bayyurt N, Turkay C. Cloning, expression and characterization of recombinant CagA protein of Helicobacter pylori using monoclonal antibodies: Its potential in diagnostics. Biologicals 2020;68:26-31. [DOI: 10.1016/j.biologicals.2020.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
71 Saribas S, Demiryas S, Yilmaz E, Uysal O, Kepil N, Demirci M, Caliskan R, Dinc HO, Akkus S, Gareayaghi N, Kirmusaoglu S, Ozbey D, Tokman HB, Koksal SS, Tasci I, Kocazeybek B. Association between human leukocyte antigen gene polymorphisms and multiple EPIYA-C repeats in gastrointestinal disorders. World J Gastroenterol 2020; 26(32): 4817-4832 [PMID: 32921959 DOI: 10.3748/wjg.v26.i32.4817] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Dos Santos Pereira E, Magalhães Albuquerque L, de Queiroz Balbino V, da Silva Junior WJ, Rodriguez Burbano RM, Pordeus Gomes JP, Barem Rabenhorst SH. Helicobacter pylori cagE, cagG, and cagM can be a prognostic marker for intestinal and diffuse gastric cancer. Infect Genet Evol 2020;84:104477. [PMID: 32736040 DOI: 10.1016/j.meegid.2020.104477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Ansari S, Yamaoka Y. Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis. Expert Rev Anti Infect Ther 2020;18:987-96. [PMID: 32536287 DOI: 10.1080/14787210.2020.1782739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
74 Neuper T, Frauenlob T, Sarajlic M, Posselt G, Wessler S, Horejs-Hoeck J. TLR2, TLR4 and TLR10 Shape the Cytokine and Chemokine Release of H. pylori-Infected Human DCs. Int J Mol Sci 2020;21:E3897. [PMID: 32486097 DOI: 10.3390/ijms21113897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
75 Tegtmeyer N, Ghete TD, Schmitt V, Remmerbach T, Cortes MCC, Bondoc EM, Graf HL, Singer BB, Hirsch C, Backert S. Type IV secretion of Helicobacter pylori CagA into oral epithelial cells is prevented by the absence of CEACAM receptor expression. Gut Pathog 2020;12:25. [PMID: 32435278 DOI: 10.1186/s13099-020-00363-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]